Harvard Business Publishing

Please click on the choices below to learn more about this product.

Amylin Pharmaceuticals: Diabetes and Beyond

Author(s): Richard G. Hamermesh and Rachel Gordon

DOI: 10.1225/809011

• Learn More or Purchase This Case
• Related Titles on This Subject
  • Corporate ventures
    • Analyzing New Venture Opportunities
    • Ashesi University
    • Bladelogic (A)
    • Buddy March
    • More...
  • Entrepreneurship
    • 3M Optical Systems: Managing Corporate Entrepreneurship
    • 3PLex.com
    • 503 Cricket Road
    • A Chinese Start-up's Midlife Crisis: 99Sushe.com
    • More...
  • Licensing
    • A Crack in the Mug: Can Starbucks Mend It?
    • A123Systems
    • AIDS in Brazil
    • Acorda Therapeutics: Rebuilding the Spinal Cord
    • More...
  • Negotiations
    • 3-D Negotiation: Playing the Whole Game
    • 3-D Negotiation: Playing the Whole Game (HBR OnPoint Enhanced Edition)
    • 3-D Negotiation: Powerful Tools to Change the Game in Your Most Important Deals (Hardcover)
    • 3M: Negotiating Air Pollution Credits (A)
    • More...
  • More...
• Other Items by the Authors
  • Richard G. Hamermesh
    • Achieving Profitable Growth and Market Value
    • Balance, Inc. (A)
    • Balance, Inc. (B)
    • BiC Pen Corp. (A), Supplement
    • More...
  • Rachel Gordon
    • Adnexus Therapeutics, Inc.: Considering the Exit
    • Cook Composites and Polymers Co.
    • Dartmouth-Hitchcock Medical Center: Spine Care
    • Differences at Work: Alex (A)
    • More...
• Business Fundamentals Series
• View All Cases

Powered by Content Directions, Inc. (CDI) and the Digital Object Identifier (DOI) View additional CDI examples     Want to Add This Link to Your Site?